Oramed Pharmaceuticals's top three insider shareholders as of March 23, 2026 are Nadav Kidron (President And Ceo, 3.36Mn shares), Miriam Kidron (Chief Scientific Officer, 1.45Mn shares), Joshua Hexter (Coo Cbo, 1.06Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Nadav Kidron | President And Ceo | 3,422,243 | 0 | 31 Mar, 2026 |
| Joshua Hexter | Coo Cbo | 1,160,384 | 0 | 18 Mar, 2026 |
| Miriam Kidron | Chief Scientific Officer | 1,133,138 | 0 | 31 Mar, 2026 |
| Avraham Gabay | Chief Financial Officer | 745,145 | 0 | 18 Mar, 2026 |
| David Silberman | Chief Financial Officer | 366,500 | 0 | 08 Jan, 2024 |
| Arie Mayer | - | 168,009 | 0 | 05 Jan, 2026 |
| Yadin Rozov | - | 155,320 | 0 | 08 Jan, 2024 |
| Netanel Derovan | Chief Legal Officer | 149,500 | 0 | 31 May, 2023 |
| Leonard Sank | - | 134,531 | 0 | 09 Jun, 2025 |
| Michael Rabinowitz | Chief Commercial Officer | 126,143 | 0 | 04 Jan, 2023 |
| Nadav Kidron | President And Ceo | 0 | 126,000 | 16 Mar, 2023 |
| Benjamin Shapiro | - | 123,220 | 0 | 05 Jan, 2026 |
| Daniel Aghion | - | 113,441 | 0 | 02 Jan, 2026 |
| Michael Rabinowitz | Chief Commercial Officer | 109,468 | 0 | 05 Jan, 2022 |
| Yehuda Reznick | - | 105,180 | 0 | 05 Jan, 2026 |
| Kevin Rakin | - | 46,661 | 0 | 22 Mar, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Mar, 2026 | Nadav Kidron | Common Stock | D | 44,818 | $3.31 | 3,422,243 | D | F |
| 30 Mar, 2026 | Miriam Kidron | Common Stock | D | 435,084 | $3.31 | 1,133,138 | D | F |
| 17 Mar, 2026 | Avraham Gabay | Common Stock | A | 95,889 | $0.00 | 745,145 | D | A |
| 17 Mar, 2026 | Miriam Kidron | Common Stock | A | 119,558 | $0.00 | 1,568,222 | D | A |
| 17 Mar, 2026 | Joshua Hexter | Common Stock | A | 95,889 | $0.00 | 1,160,384 | D | A |
| 17 Mar, 2026 | Nadav Kidron | Common Stock | A | 167,005 | $0.00 | 3,422,243 | D | A |
| 12 Mar, 2026 | Nadav Kidron | Common Stock | D | 100,000 | $0.00 | 3,255,238 | D | G |
| 22 Jan, 2026 | Joshua Hexter | Common Stock | A | 19,000 | $0.00 | 1,064,495 | D | M |
| 22 Jan, 2026 | Avraham Gabay | Common Stock | A | 19,000 | $0.00 | 649,256 | D | M |
| 22 Jan, 2026 | Miriam Kidron | Common Stock | A | 19,000 | $0.00 | 1,448,664 | D | M |
| 22 Jan, 2026 | Nadav Kidron | Common Stock | A | 109,000 | $0.00 | 3,355,238 | D | M |
| 22 Jan, 2026 | Nadav Kidron | Performance Stock Units | D | 109,000 | $0.00 | 0 | D | M |
| 22 Jan, 2026 | Miriam Kidron | Performance Stock Units | D | 19,000 | $0.00 | 0 | D | M |
| 22 Jan, 2026 | Joshua Hexter | Performance Stock Units | D | 19,000 | $0.00 | 0 | D | M |
| 22 Jan, 2026 | Avraham Gabay | Performance Stock Units | D | 19,000 | $0.00 | 0 | D | M |
| 14 Jan, 2026 | Miriam Kidron | Common Stock | D | 86,166 | $0.00 | 1,343,498 | D | G |
| 31 Dec, 2025 | Miriam Kidron | Common Stock | A | 121,331 | $0.00 | 1,314,664 | D | A |
| 31 Dec, 2025 | Nadav Kidron | Common Stock | A | 232,640 | $0.00 | 2,919,238 | D | A |
| 31 Dec, 2025 | Joshua Hexter | Common Stock | A | 97,328 | $0.00 | 930,495 | D | A |
| 31 Dec, 2025 | Benjamin Shapiro | Common Stock | A | 30,000 | - | 119,720 | D | A |